XML 62 R46.htm IDEA: XBRL DOCUMENT v3.22.1
QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)
12 Months Ended
Mar. 31, 2022
Quarterly Financial Data [Abstract]  
Schedule of Quarterly Financial Information

Summary quarterly results for the years ended March 31, 2022 and March 31, 2021 are as follows:

 

 

 

Three Months Ended

 

 

 

 

 

 

 

Jun 30, 2021

 

 

Sep 30, 2021

 

 

Dec 31, 2021

 

 

March 31, 2022

 

 

Total

 

 

 

(in thousands, except per share amounts)

 

 

 

 

 

Total revenue

 

$

35,101

 

 

$

36,510

 

 

$

30,714

 

 

$

22,058

 

 

$

124,383

 

Gross profit

 

$

10,230

 

 

$

10,788

 

 

$

7,641

 

 

$

5,253

 

 

$

33,912

 

Net income (loss)

 

$

2,510

 

 

$

3,659

 

 

$

1,102

 

 

$

(1,180

)

 

$

6,091

 

Basic net income (loss) per share

 

$

0.08

 

 

$

0.12

 

 

$

0.04

 

 

$

(0.04

)

 

$

0.20

 

Shares used in basic per share calculation

 

 

30,860

 

 

 

31,031

 

 

 

31,085

 

 

 

31,097

 

 

 

31,018

 

Diluted net income (loss) per share

 

$

0.08

 

 

$

0.12

 

 

$

0.04

 

 

$

(0.04

)

 

$

0.19

 

Shares used in diluted per share calculation

 

 

31,290

 

 

 

31,288

 

 

 

31,235

 

 

 

31,097

 

 

 

31,295

 

 

 

 

Three Months Ended

 

 

 

 

 

 

 

Jun 30, 2020

 

 

Sep 30, 2020

 

 

Dec 31, 2020

 

 

Mar 31, 2021

 

 

Total

 

 

 

(in thousands, except per share amounts)

 

 

 

 

 

Total revenue

 

$

10,811

 

 

$

26,281

 

 

$

44,251

 

 

$

35,497

 

 

$

116,840

 

Gross profit

 

$

2,635

 

 

$

7,263

 

 

$

11,006

 

 

$

9,220

 

 

$

30,124

 

Net income (loss) (1)

 

$

(2,219

)

 

$

1,914

 

 

$

4,315

 

 

$

22,124

 

 

$

26,134

 

Basic net income (loss) per share (1)

 

$

(0.07

)

 

$

0.06

 

 

$

0.14

 

 

$

0.72

 

 

$

0.85

 

Shares used in basic per share calculation

 

 

30,352

 

 

 

30,669

 

 

 

30,736

 

 

 

30,782

 

 

 

30,635

 

Diluted net income (loss) per share (1)

 

$

(0.07

)

 

$

0.06

 

 

$

0.14

 

 

$

0.71

 

 

$

0.83

 

Shares used in diluted per share calculation

 

 

30,352

 

 

 

31,170

 

 

 

31,320

 

 

 

31,295

 

 

 

31,304

 

 

(1)

Includes $20.9 million of tax benefit related to the release of the valuation allowance on deferred tax assets during the three months ended March 31, 2021.